Chemical process for fluorinating a tertiary carbon atom in the steroid
nucleus
    3.
    发明授权
    Chemical process for fluorinating a tertiary carbon atom in the steroid nucleus 失效
    用于氟化类固醇核中叔碳原子的化学方法

    公开(公告)号:US4284558A

    公开(公告)日:1981-08-18

    申请号:US775879

    申请日:1977-03-09

    摘要: Saturated organic compounds containing a hydrogen atom bound to a tertiary carbon atom may be electrophilically fluorinated by reaction with an electrophilic fluorinating agent such as molecular fluorine or trifluoromethyl hypofluorite under conditions whereby the formation of free fluorine radicals is suppressed, e.g. by the presence of a free radical inhibitor such as oxygen or nitrobenzene, the reactants being substantially homogeneously dispersed in a liquid medium, e.g. a solvent medium such as fluorotrichloromethane or chloroform/fluorotrichloromethane, so that the said hydrogen atom is electrophilically replaced by a fluorine atom. The fluorination is highly selective and, in the case of complex substrates such as saturated steroids which contain a number of tertiary C--H bonds, may be substantially completely confined to replacement of the hydrogen atom at the tertiary carbon atom which has the highest electron density about the C--H bond. The electron density and thus the direction of the fluorination may be controlled by appropriate selection of substituent groupings in the substrate molecule.Novel 14.alpha.-fluorosteroids are also disclosed, including compounds having valuable androgenic or progestational activity and useful synthetic intermediates.

    摘要翻译: 含有与叔碳原子结合的氢原子的饱和有机化合物可以通过与亲电氟化剂如分子氟或三氟甲基次氟酸荧光反应,在抑制游离氟自由基形成的条件下进行亲电氟化。 通过存在自由基抑制剂如氧或硝基苯,反应物基本均匀地分散在液体介质中,例如, 溶剂介质如氟三氯甲烷或氯仿/氟三氯甲烷,使所述氢原子被氟原子亲电取代。 氟化是高度选择性的,并且在复杂的底物例如含有多个叔CH键的饱和类固醇的情况下,可以基本上完​​全限制于在具有最高电子密度的叔碳原子上的氢原子的取代 CH键。 可以通过适当选择底物分子中的取代基组来控制电子密度以及氟化方向。 还公开了新的14种α-氟甾类,包括具有有价值的雄激素或促孕活性的化合物和有用的合成中间体。

    Chemical process for preparing .DELTA.9(11) dehydrosteroids
    7.
    发明授权
    Chemical process for preparing .DELTA.9(11) dehydrosteroids 失效
    制备{66 9(11)脱氢甾醇的化学方法

    公开(公告)号:US4064148A

    公开(公告)日:1977-12-20

    申请号:US688714

    申请日:1976-05-21

    CPC分类号: C07J41/005 C07J5/0076

    摘要: The Specification describes a synthetic route for the preparation of a 9,11-dehydro-3-oxygenated 17.alpha.-hydroxy-20-ketopregnane which comprises the steps (i) electrophilically fluorinating a saturated 9,11-unsubstituted 3-oxygenated-17.alpha.-(esterified hydroxy)-20-ketopregnane, (ii) dehydrofluorinating the resulting 9.alpha.-fluorosteroid, if desired after transformations elsewhere in the molecule have been effected, and (iii) cleaving the ester group at the 17.alpha.-position to generate a 17.alpha.-hydroxy group.

    摘要翻译: 该说明书描述了用于制备9,11-脱氢-3-氧化的17α-羟基-20-酮戊二酸的合成路线,其包括步骤(i)亲和氟化饱和9,11-未取代的3-氧化-17α- (酯化羟基)-20-酮戊二醇,(ii)如果需要,在所述分子中其它地方进行转化后,将所得9α-氟类固醇脱氟化氢,和(iii)在17α位置切割酯基以产生 17α-羟基。

    Chemical compounds and process
    8.
    发明授权
    Chemical compounds and process 失效
    化合物和工艺

    公开(公告)号:US5472957A

    公开(公告)日:1995-12-05

    申请号:US104496

    申请日:1993-08-10

    IPC分类号: A61K31/59

    CPC分类号: A61K31/59

    摘要: The invention provides novel compositions for use in pharmaceutical and veterinary medicine which contain 1.alpha.-hydroxy vitamin D compounds. Particular compositions are described which contain steroids which induce or assist in combatting osteoporosis together with 1.alpha.-hydroxy vitamin D.sub.3 or 1.alpha.,25-dihydroxy vitamin D.sub.3. Methods of treatment of diseases are also provided including many which are resistant to vitamin D.sub.3, in particular bone diseases.

    摘要翻译: 本发明提供了用于含有1α-羟基维生素D化合物的药物和兽医学中的新型组合物。 描述了包含诱导或协助与1α-羟基维生素D3或1α,25-二羟基维生素D3一起对抗骨质疏松症的类固醇的特定组合物。 还提供了治疗疾病的方法,包括许多对维生素D3,特别是骨疾病有抗性的疾病。

    1-.alpha.-hydroxy vitamin D compounds and process for preparing same
    9.
    发明授权
    1-.alpha.-hydroxy vitamin D compounds and process for preparing same 失效
    1-羟基维​​生素D化合物及其制备方法

    公开(公告)号:US4670190A

    公开(公告)日:1987-06-02

    申请号:US657270

    申请日:1984-10-03

    IPC分类号: C07J9/00

    CPC分类号: C07J9/00

    摘要: The invention provides novel 1.alpha.-hydroxy vitamin D compounds and a method for their preparation from 1.alpha.-hydroxy-25-hydrogen cholesta-5,7-dienes by irradiation and isomerization techniques. The invention also includes the said 1.alpha.-hydroxy-25-hydrogen-cholesta-5,7-dienes and the corresponding cholest-5-enes.The new compounds may be obtained in a crystalline form substantially free from isomeric or other impurities arising from manufacture.

    摘要翻译: 本发明提供新颖的1α-羟基维生素D化合物及其通过照射和异构化技术从1α-羟基-25-氢胆甾醇-5,7-二烯制备的方法。 本发明还包括所述的1α-羟基-25-氢 - 胆甾烯-5,7-二烯和相应的胆甾-5-烯。 新化合物可以以基本上不含由制造产生的异构体或其它杂质的结晶形式获得。